Organization
Repros Therapeutics, Inc.
Topic
All Topics
People
Find news about people
Alumni
Find news on alumni of any org
Industries
Find news on a particular market
Your Contacts
Find news on your contacts
Sign up for free daily alerts on this feed:
By pressing Sign Up, you agree to our Terms of Use, Privacy Policy, and the LexisNexis Terms & Conditions

Follow

Change Feed
Repros Therapeutics, Inc.
... York (January 5, 2018, 4:03 PM EST) -- Reproductive disorder drugmaker Repros Therapeutics Inc. has been hit with a stockholder suit in Delaware federal court ...
... for all current investors, traders, and shareholders of Athersys, Inc. (NASDAQ:ATHX), Repros Therapeutics Inc. (NASDAQ:RPRX), GCP Applied Technologies Inc. (NYSE:GCP), IDACORP, Inc. (NYSE:IDA), Mobile Mini, ...
... free research to the investment community. Today we are offering reports on RPRX, ALDX, NEOT, and BLRX which can be accessed for free by signing ...
... THE WOODLANDS, Texas, Dec. 12, 2017 (GLOBE NEWSWIRE) -- Repros Therapeutics Inc. (NASDAQ:RPRX) ("Repros" or the "Company") today announced that it has entered ...
... Allergan has struck a deal to acquire the floundering Repros Therapeutics. The bargain-basement takeout gives Allergan the rights to a uterine fibroid ...
... THE WOODLANDS, Texas, Nov. 13, 2017 (GLOBE NEWSWIRE) -- Repros Therapeutics Inc.® (Nasdaq:RPRX) today announced financial results for the third quarter ended September ...
... companies operating in this pipeline space include Lipocine, M et P Pharma, Repros Therapeutics and TesoRx Pharma. https://www.reportlinker.com/p05142592 Read the full report: Erectile dysfunction is ...
... If you want a Stock Review on NEOT, PIRS, or RPRX then come over tohttp://dailystocktracker.com/register/and sign up for your free customized report today. ...
... THE WOODLANDS, Texas, Aug. 14, 2017 (GLOBE NEWSWIRE) -- Repros Therapeutics Inc.® (Nasdaq:RPRX) today announced financial results for the second quarter ended June ...
... Repros Assessing Uterine Fibroid and Endometriosis Development Program with Vaginal Drug Delivery Treatment ...
... announces that it is investigating claims on behalf of investors of Repros Therapeutics Inc. ("Repros" or the "Company") (Nasdaq: RPRX). If you purchased or otherwise ...
... THE WOODLANDS, Texas, May 18, 2017 (GLOBE NEWSWIRE) -- Repros Therapeutics Inc (Nasdaq:RPRX) ("Repros" or the "Company"), announced today that it has entered ...
... THE WOODLANDS, Texas, May 09, 2017 (GLOBE NEWSWIRE) -- Repros Therapeutics Inc.® (Nasdaq:RPRX) today announced financial results for the first quarter ended March ...
... THE WOODLANDS, Texas, April 17, 2017 (GLOBE NEWSWIRE) -- Repros Therapeutics Inc.® (Nasdaq:RPRX) today announced the issuance of a new patent, U.S. Patent ...
... Repros Therapeutics Inc. has announced that the company held a meeting with the FDA ...
... THE WOODLANDS, Texas, April 10, 2017 (GLOBE NEWSWIRE) -- Repros Therapeutics Inc.® (Nasdaq:RPRX) today announced that the Company's Board of Directors has appointed ...
... THE WOODLANDS, Texas, March 31, 2017 (GLOBE NEWSWIRE) -- Repros Therapeutics Inc.® (Nasdaq:RPRX) today announced financial results for the fourth quarter and year ...
... THE WOODLANDS, Texas, March 31, 2017 (GLOBE NEWSWIRE) -- Repros Therapeutics Inc.® (Nasdaq:RPRX) today announced financial results for the fourth quarter and year ...
... THE WOODLANDS, Texas, Feb. 02, 2017 (GLOBE NEWSWIRE) -- Repros Therapeutics Inc.®�(Nasdaq:RPRX) today announced that Joseph S. Podolski is leaving his position as ...
... Repros Therapeutics Inc. has announced the FDA has granted an end of Phase II ...
... Repros Therapeutics Inc. has requested a meeting with the FDA to discuss Phase III ...
... THE WOODLANDS, Texas, Dec. 19, 2016 (GLOBE NEWSWIRE) -- Repros Therapeutics Inc.® (Nasdaq:RPRX) today announced it has requested a meeting to discuss Phase ...
Want to see the full history on Repros Therapeutics, Inc.? Upgrade to RelSci Pro now!
Start My Free Trial